{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:42:28Z","timestamp":1790685748280,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/jcp.0b013e3181ac4aaf","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T03:27:35Z","timestamp":1246591655000},"page":"372-377","source":"Crossref","is-referenced-by-count":104,"title":["Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depressive Disorder"],"prefix":"10.1097","volume":"29","author":[{"given":"Andrew F.","family":"Leuchter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.psych.59.113006.095941","article-title":"A comprehensive review of the placebo effect: recent advances and current thought.","volume":"59","author":"Price","year":"2008","journal-title":"Annu Rev Psychol"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/YCO.0b013e3282f50c36","article-title":"Neurophysiology and psychobiology of the placebo response.","volume":"21","author":"Klosterhalfen","year":"2008","journal-title":"Curr Opin Psychiatry"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jpsychires.2007.10.004","article-title":"The persistence of the placebo response in antidepressant clinical trials.","volume":"42","author":"Khan","year":"2008","journal-title":"J Psychiatr Res"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biopsych.2003.11.019","article-title":"Placebo mechanisms and reward circuitry: clues from Parkinson's disease.","volume":"56","author":"de la Fuente-Fernandez R, Schulzer","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/jn.1998.80.1.1","article-title":"Predictive reward signal of dopamine neurons.","volume":"80","author":"Schultz","year":"1998","journal-title":"J Neurophysiol"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.1067176","article-title":"Placebo and opioid analgesia-imaging a shared neuronal network.","volume":"295","author":"Petrovic","year":"2002","journal-title":"Science"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1176\/appi.ajp.159.5.728","article-title":"The functional neuroanatomy of the placebo effect.","volume":"159","author":"Mayberg","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0166-2236(02)02181-1","article-title":"The placebo effect in Parkinson's disease.","volume":"25","author":"de la Fuente-Fernandez R, Stoessl","year":"2002","journal-title":"Trends Neurosci"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1523\/JNEUROSCI.4547-03.2004","article-title":"Noradrenaline and dopamine efflux in the prefrontal cortex in relation to appetitive classical conditioning.","volume":"24","author":"Mingote","year":"2004","journal-title":"J Neurosci"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1523\/JNEUROSCI.23-05-01879.2003","article-title":"Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release.","volume":"23","author":"Ventura","year":"2003","journal-title":"J Neurosci"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/cercor\/bhi066","article-title":"Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens.","volume":"15","author":"Ventura","year":"2005","journal-title":"Cereb Cortex"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.neuro.28.061604.135709","article-title":"An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance.","volume":"28","author":"Aston-Jones","year":"2005","journal-title":"Annu Rev Neurosci"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cne.20723","article-title":"Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance.","volume":"493","author":"Aston-Jones","year":"2005","journal-title":"J Comp Neurol"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1523\/JNEUROSCI.3038-04.2005","article-title":"Noradrenaline and dopamine elevations in the rat prefrontal cortex in spatial working memory.","volume":"25","author":"Rossetti","year":"2005","journal-title":"J Neurosci"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1523\/JNEUROSCI.2391-08.2008","article-title":"Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo.","volume":"44","author":"Mickey","year":"2008","journal-title":"J Neurosci"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/107385840100700406","article-title":"Reward signaling by dopamine neurons.","volume":"7","author":"Schultz","year":"2001","journal-title":"Neuroscientist"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","article-title":"The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes.","volume":"42","author":"Berridge","year":"2003","journal-title":"Brain Res Brain Res Rev"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1155\/NP.2004.191","article-title":"Norepinephrine and dopamine as learning signals.","volume":"11","author":"Harley","year":"2004","journal-title":"Neural Plast"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nn1250","article-title":"Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus.","volume":"7","author":"Benedetti","year":"2004","journal-title":"Nat Neurosci"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00512935","article-title":"Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons.","volume":"333","author":"Oreland","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/sj.npp.1300542","article-title":"The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.","volume":"29","author":"Bilder","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R22-12-20210128","first-page":"383","article-title":"Human monoamine oxidase A gene determines levels of enzyme activity.","volume":"49","author":"Hotamisligil","year":"1991","journal-title":"Am J Hum Genet"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2156-6-46","article-title":"MAOA haplotypes associated with thrombocyte-MAO activity.","volume":"6","author":"Jansson","year":"2005","journal-title":"BMC Genet"},{"key":"R24-12-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.mp.4002020","article-title":"Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality.","volume":"13","author":"Buckholtz","year":"2008","journal-title":"Mol Psychiatry"},{"key":"R25-12-20210128","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G","article-title":"Association of codon 108\/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.","volume":"67","author":"Lachman","year":"1996","journal-title":"Am J Med Genet"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1176\/appi.ajp.159.1.122","article-title":"Changes in brain function of depressed subjects during treatment with placebo.","volume":"159","author":"Leuchter","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"4","key":"R28-12-20210128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0447.2008.01305.x","article-title":"Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression.","volume":"119","author":"Hunter","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008571-199606000-00007","article-title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.","volume":"6","author":"Lachman","year":"1996","journal-title":"Pharmacogenetics"},{"key":"R30-12-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajmg.b.30462","article-title":"The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.","volume":"144B","author":"Tadic","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.npp.1300506","article-title":"Discovering endophenotypes for major depression.","volume":"29","author":"Hasler","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R32-12-20210128","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression.","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R33-12-20210128","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.mp.4001502","article-title":"Investigation of serotonin-related genes in antidepressant response.","volume":"9","author":"Peters","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R34-12-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00041444-200412000-00007","article-title":"Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders.","volume":"14","author":"Gutierrez","year":"2004","journal-title":"Psychiatr Genet"},{"key":"R35-12-20210128","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/sj.npp.1300785","article-title":"Association study of a monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response.","volume":"30","author":"Yu","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"R36-12-20210128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tins.2007.12.006","article-title":"MAOA and the neurogenetic architecture of human aggression.","volume":"31","author":"Buckholtz","year":"2008","journal-title":"Trends Neurosci"},{"key":"R37-12-20210128","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1523\/JNEUROSCI.0439-05.2005","article-title":"Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.","volume":"25","author":"Zubieta","year":"2005","journal-title":"J Neurosci"},{"key":"R38-12-20210128","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archpsyc.63.7.808","article-title":"Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate\/nucleus accumbens.","volume":"63","author":"Brody","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R39-12-20210128","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.npp.1300987","article-title":"Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine.","volume":"31","author":"Villegier","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R40-12-20210128","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S1461145705006218","article-title":"Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males.","volume":"9","author":"Jin","year":"2006","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200908000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:51:53Z","timestamp":1786038713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200908000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181ac4aaf","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}